Squamous Non-Small Cell Lung Cancer Therapeutics Report

By www.reliablebusinessarena.com

Report Details

Report Name

Global And United States Squamous Non-Small Cell Lung Cancer Therapeutics Market Report & Forecast 2024-2031 Story

Pages

105

Price

$ 4350

Features

Squamous Non-Small Cell Lung Cancer Therapeutics Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Ascenta Therapeutics, Inc.
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Bayer AG
BIND Therapeutics, Inc.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Five Prime Therapeutics, Inc.
Genentech, Inc.
Incyte Corporation
Johnson & Johnson
MacroGenics, Inc.
Novartis AG
Oncogenex Pharmaceuticals, Inc.
PsiOxus Therapeutics Limited